HighVista Strategies’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,780
Closed -$652K 139
2020
Q3
$652K Buy
4,780
+556
+13% +$59.1K 0.48% 24
2020
Q2
$408K Buy
+4,224
New +$352K 0.34% 61

HighVista Strategies's MYOK Position: Q4 2020 in Review

HighVista Strategies sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 4,780 shares — an estimated $652K sold.

HighVista Strategies first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $652K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • HighVista Strategies reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • HighVista Strategies sold 4,780 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $652K.
  • HighVista Strategies first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • HighVista Strategies's MyoKardia, Inc. Common Stock position peaked at $652K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on HighVista Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.